Authors


Luke Peppone, PhD

Latest:

Luke Peppone on the Need for Trials With Medical Marijuana

Luke Peppone discusses the need for more trials testing the efficacy of medical cannabis.


Matthew Burke, MBA, RN, MSN, APRN-BC

Latest:

Matthew Burke on Potential Challenges Facing Nurses in the Field of Immunotherapy

Matthew Burke, MBA, RN, MSN, APRN-BC, Oncology Nurse Practitioner/Melanoma and Renal Cell Carcinoma, Yale New Haven Hospital, discusses potential challenges nurses might face with the new advent on immunotherapy.


Mary K. Caffrey

Latest:

Big Changes Anticipated in Treatment Paradigms

Clinicians who treat patients with multiple myeloma have witnessed a sea change in the past 15 years.


Kerrie L. Girard, RN, BSN

Latest:

Screening and Management: Distress and the Nurse Navigator, Part II

Cancer and its treatment creates or aggravates psychosocial distress, while unresolved physical and practical problems can also add to the distress of patients attempting to complete their treatment and recovery.


Amy Callahan, RN, DNP, CRNP, AOCNS

Latest:

Amy Callahan on Barriers to Safe Handling

Amy Callahan, RN, DNP, CRNP, AOCNS, nurse manager, Sidney Kimmel Cancer Center at Thomas Jefferson University, discusses barriers to safe handling of chemotoxic materials.


Janet Deatrick, PhD, RN, FAAN

Latest:

Janet Deatrick on Neurocognitive Late Effects in CBT Survivors

Janet Deatrick, PhD, RN, FAAN, University of Pennsylvania School of Nursing, discusses neurocognitive late effects among survivors of childhood brain tumors (CBTs).



Kara Yannotti, MMH, RN, Elizabeth McCarthy, MSN, RN, Sabrina Kdiry, BSN, RN

Latest:

A Guide to Nursing Discharge of Patients Receiving CAR T-Cell Therapy

Standardized and focused education for patients receiving CAR T-cell therapy and their caregivers should be part of discharge procedures.


Marianne J. Davies, NP

Latest:

Marianne J. Davies, NP, Discusses the Peer Review Process at Yale Cancer Center

Marianne J. Davies, NP, Yale Cancer Center, discusses the peer review process at Yale Cancer Center.


Sharon Tollin, PhD, ARNP-BC, OCN®

Latest:

Sharon Tollin on Research Into Risk-Reducing Surgery

Sharon Tollin, PhD, ARNP-BC, OCN®, discusses the unmet need for information regarding patients who have undergone prophylactic risk-reducing surgery (such as mastectomy and removal of tubes and ovaries).


Sonia Pacheco, MSW, LSW, LCSW, Hispanic Outreach Program Coordinator, CancerCare

Latest:

Hope, Gratitude, and Spirituality: What They Mean to Patients with Cancer

Nurses, doctors, social workers, and the rest of the medical team and facility staff at treatment centers have the ability to bring hope, gratitude, peace, and love, all part of spirituality—to their patients.


Aaron Spitz, MD

Latest:

Aaron Spitz on Telemedicine's Impact on Nurses' Responsibilities

Aaron Spitz, MD, Orange County Urology Associates, discusses how telemedicine is expanding nurses' roles and responsibilities in caring for patients.


David G. Maloney, MD, PhD

Latest:

Expert Discusses Challenges of Using CAR T-Cell Therapy to Treat Diffuse Large B-Cell Lymphoma

CAR T-cell therapy is changing the landscape of cancer care, but challenges for certain cancer types still remain.


Sandra Blackburn, MSW

Latest:

Answering Those "Million Dollar" Questions

Two nurse navigators report on the importance of equitable access to care, regardless of a patient's social connections, socioeconomic status, of philanthropy history.



Emily Johnston, MD

Latest:

Emily Johnston on End-of-Life Care Differences Between Older and Younger Patients

Emily Johnston, MD, fellow at Lucile Packard Children’s Hospital Stanford, discusses the differences between end-of-life care in adolescent and young adult (AYA) patients and older patients with cancer.


Kristie Howlett, MS, RN

Latest:

Kristie Howlett on her Patient Hand Wiping Trial

Kristie Howlett from Sutter Roseville Medical Center on her Patient Hand Wiping Trial


Marianne Davies, RN, MSN, ACNP, AOCN

Latest:

Marianne Davies Discusses Side Effects Associated With Immunotherapy

Marianne Davies, RN, MSN, ACNP, AOCN, Smilow Cancer Hospital, Yale School of Nursing, discusses the side effects associated with immunotherapy.


Douglas B. Johnson, MD

Latest:

Melanoma Advances: Where We Are and Where We're Going

Combination therapy has been the biggest recent advance in the melanoma space, but there is still more work to be done, according to Douglas B. Johnson, MD.



Dennis Bittner, PhD

Latest:

Nurses at the Frontline of Important Discussions of Treatment-Related Sexual Side Effects

Nearly half of cancer patients do not discuss sexuality with their healthcare providers, but that doesn't mean it isn't a concern for them.


Deanna J. Attai, MD

Latest:

Dr. Attai on Managing Pain in Breast Cancer Patients

Deanna J. Attai, MD, breast surgeon, assistant clinical professor of surgery, David Geffen School of Medicine, University of California, Los Angeles, gives advice to nurses on how to manage pain in breast cancer patients.


Uri Goldberg, MD

Latest:

Uri Goldberg Outlines Steps For Improving Pain Management

Uri Goldberg lays out important steps for improving the pain management of patients with cancer.


Debi Fischer, RN, LCSW

Latest:

Using AI as an Oncology Nurse

Oncology nurses may play a role in the utilization of artificial intelligence in the clinical setting.


Carmante Extra, DNP, MSNEd, APRN, FNP-BC

Latest:

Cancer Care During COVID-19: Nurses Share Their Perspectives

The pandemic may elicit fear, but nurses’ dedication to their patients remains steadfast.


Margaret Rummel, MHA, OCN, NE-BC

Latest:

The Power of Teamwork: Navigating Patients With Complex Needs

We all have been called on to treat complex patients crystalize how optimal oncology care depends on the collaboration of a multidisciplinary team, and such is the case with this patient transferred to our cancer center’s head and neck division.


Association of Community Cancer Centers

Latest:

ACCC Marks 15th Anniversary of Oncology Pharmacy Education Network

ACCC is celebrating the 15th anniversary of Oncology Pharmacy Education Network by honoring its founders.



Juanita Madison, MN, RN

Latest:

Juanita Madison Describes the Provenge Treatment Process

Juanita Madison from Seattle Cancer Care Alliance Describes the Provenge Treatment Process


Michael Birrer, MD, PhD

Latest:

Michael Birrer on Predicting Outcomes in Ovarian Cancer

Michael Birrer, MD, PhD, Harvard Medical School, discusses what he hopes to discover as factors that influence long-term survival in patients and survivors with ovarian cancer.